Please login to the form below

Not currently logged in
Email:
Password:

The Harmony Alliance gathers to battle blood cancer

Uses its big data platform to analyse the disease

blood cellsAt the 2nd general assembly based in Berlin, Germany last week, 120 representatives from the Innovative Medicines Initiative’s (IMI) Harmony Alliance all gathered to discuss achievements and objectives surrounding blood cancer.

The alliance, which brings together 51 partners and key stakeholders from eleven European countries, uses its big data platform to better understand blood cancer and contribute to improving targeted therapies.

Michel Van Speybroeck, director of data sciences, Janssen, said: “Public and private partners are bringing together their best people, data and knowledge to solve key questions on haematological cancers.

“These challenges can only be met by applying the most advanced technology and it’s wonderful to see from the front-line how this is being shaped by the Harmony Alliance.”

The alliance aims to offer an ethical and legal framework on the use of medical data, using its new platform for analysis and defining “standard sets of outcomes”.

Article by
Gemma Jones

30th October 2017

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...